CTI BioPharma (FRA:CEPS) Total Operating Expense : €119.90 Mil (TTM As of Mar. 2023)

View and export this data going back to 2007. Start your Free Trial

What is CTI BioPharma Total Operating Expense?

CTI BioPharma's Total Operating Expense for the three months ended in Mar. 2023 was €30.00 Mil. CTI BioPharma's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2023 was €119.90 Mil.

CTI BioPharma Total Operating Expense Historical Data

The historical data trend for CTI BioPharma's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTI BioPharma Total Operating Expense Chart

CTI BioPharma Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Operating Expense

Get a 7-Day Free Trial

50.67

38.94

39.27

84.37

122.94

CTI BioPharma Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Total Operating Expense	Get a 7-Day Free Trial															33.70	28.66	29.60	31.64	30.00

CTI BioPharma Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.

Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €119.90 Mil.

CTI BioPharma Total Operating Expense Related Terms

Thank you for viewing the detailed overview of CTI BioPharma's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

CTI BioPharma (FRA:CEPS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CTI BioPharma Corp (FRA:CEPS) » Definitions » Total Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

3101 Western Avenue, Suite 800, Seattle, WA, USA, 98121

Website

https://www.ctibiopharma.com

CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood-related cancers. Its products under the pipeline include Pacritinib. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.

CTI BioPharma (FRA:CEPS) Headlines

No Headlines